HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Global Consumer Health Market Expected To Bounce Back Post-COVID

Executive Summary

Following a challenging 2020, global OTC growth will recover in 2021, “and even get stronger” going into 2022 and 2023, IQVIA Consumer Health's Amit Shukla told delegates at the AESGP's 57th Annual Meeting.

You may also be interested in...



COVID-Driven US Online Consumer Heath Sales Winners: Walmart, Instacart And Pain Relief OTCs

Results from 1010data's Health & Wellness Spotlight report show online sales of pain relief product in US during 2020 increased 164%, with sales also growing strong in the allergy relief, 143%, and cough/cold, 131%, categories.

AESGP Annual Meeting, Day 2: Communicating Risk, E-Commerce Boom, RWE And Sustainability

Day two of the AESGP's 57th Annual Meeting featured discussions on communicating risk in times of uncertainty, how to foster a harmonized EU market for food supplements and the growth of the ePharmacy channel. The opportunities presented by real-world evidence were also debated, along with the challenges facing the self-care industry in the area of sustainability.

AESGP Annual Meeting, Day 1: Life After COVID-19, The Value Of Self-Care And MDR Implementation

Opportunities, challenges and lessons learnt from the global COVID-19 pandemic was the theme of the AESGP's 57th Annual Meeting. Day one of the conference explored the future of consumer healthcare in a post-pandemic world, the growing role of self-care and the implementation of the new Medical Devices Regulation.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel